January 9, 2008 NASD OTC-BB: MRDAF (MARKET WIRE)

Meridian Co., Ltd.: Lapex 2000 LipoLaser Global Distribution Now Includes the Persian Gulf

Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that they have signed an exclusive distribution agreement for the Persian Gulf with Laser Lipo (Dubai) Ltd. ("Laser Lipo").

The contract outlines that Laser Lipo will be granted an exclusive license to market the LAPEX 2000 BCS ("BCS") in the Persian Gulf, focusing primarily in Dubai. Their exclusive distributorship for the BCS is based on a minimum order volume equal to sales of approximately US $16 million for the three year term of the contract.

The Lipo Laser is "not just a body contouring system, in some cases, it can be a lifestyle changing experience. We look forward to introducing the BCS in to the gulf region, which has one of the highest percentages of wealth in the world," says Ian Cobley, Director of Laser Lipo Ltd.

"Laser Lipo plans on distributing the BCS through their affiliate company, CPL International LLC in the Gulf region and directly in the UK. We feel confident that we can surpass our anticipated sales of over 2 million in the initial 12 months from our UK launch," says Sharon Cobley, Director of Laser Lipo Ltd. She continues; "Our knowledge and connections with leading European cosmetic surgeons, coupled with our experience in the aesthetic arena, assures us that this technology is just what the whole industry has been waiting for- a risk free alternative to invasive procedures such as liposuction."

More about: Laser Lipo Ltd.

Laser Lipo is a privately owned company based in the UK with offices in Dubai. The management team has many years of experience at the top end of the beauty industry, including semi permanent make-up, Microdermabrasion, Botox¢ç, facial line fillers, Laser hair removal and medical skin peels.

More about: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 2000 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centres in Korea, USA, Canada, China, Japan, Mexico and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca